Skip to main content
. 2016 Dec 5;6(2):266–270. doi: 10.3892/mco.2016.1101

Table I.

Demographics of the patients.

Variable No. of patients (n=89) %
Age (year, average ± SD) 50.9±11.3
BMI (kg/m2, average ± SD) 22.3±3.6
WHO BMI classification
  Underweight (BMI <18.5 kg/m2)   9 10
  Normal range (18.5≤ BMI <25 kg/m2) 59 66
  Overweight (25≤ BMI <30 kg/m2) 19 21
  Obese (BMI ≥30 kg/m2)   2   3
Menopausal status
  Premenopausal 40 45
  Postmenopausal 49 55
T stage
  1 16 18
  2 53 60
  3   8   9
  4 12 13
N stage
  0 41 46
  1 36 40
  2   2   2
  3 10 12
Subtypes
  ER+, HER 31 35
  ER+, HER+ 20 22
  HER2 type 14 16
  Triple negative type 24 27
Neoadjuvant chemotherapy
  Yes 47 53
  No 42 47
Adjuvant chemotherapy
  Yes 36 40
  No 53 60
Recurrent site
  Local 21 24
  Lymph node 17 19
  Lung 15 17
  Liver 11 12
  Bone 12 13
  Brain   6   7
  Other   7   8

SD, standard deviation; BMI, body mass index; WHO, World Health Organization; ER, estrogen receptor; HER, human epidermal growth factor 2 receptor.